Biofield Therapies: Guidelines for Reporting Clinical Trials

被引:1
|
作者
Hammerschlag, Richard [1 ,2 ]
Sprengel, Meredith [3 ]
Baldwin, Ann L. [4 ]
机构
[1] Consciousness & Healing Initiat, 6919 La Jolla Blvd, San Diego, CA 92037 USA
[2] NOVA Inst Hlth, Baltimore, MD USA
[3] Netherlands Org Appl Sci Res TNO, Human Factors, Soesterberg, Netherlands
[4] Univ Arizona, Dept Physiol, Tucson, AZ USA
关键词
biofield therapies; biofield therapy clinical trials; reporting guidelines; RANDOMIZED CONTROLLED-TRIALS; EXTERNAL QIGONG; HEALING TOUCH; QI-THERAPY; RADIATION-THERAPY; DOUBLE-BLIND; CONSORT; REIKI; CANCER; EXTENSION;
D O I
10.1177/27536130231202501
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
A set of guidelines has been developed to help improve reporting of clinical trials of biofield therapies. The need for enhanced transparency when reporting trials of this family of integrative health practices, eg, External Qigong, Healing Touch, Reiki and Therapeutic Touch, has been advocated in systematic reviews of these studies. The guidelines, called Biofield Therapies: Reporting Evidence Guidelines (BiFi REGs), supplement CONsolidated Standards of Reporting Trials (CONSORT) 2010 by including details of the intervention protocols relevant to biofield therapy trials. BiFi REGs evolved through a draft document created by a core group, two rounds of a Delphi process with an international group of subject matter experts and two panels, meeting via Zoom, which included editors of complementary and integrative medicine journals. BiFi REGs comprises a 15-item Intervention checklist. Modifications of two other CONSORT topic areas are also proposed to enhance their relevance to trials of biofield therapies. Included for each item are an explanation, and exemplars of reporting from peer-reviewed published reports of biofield therapy trials. When used in conjunction with all other items from CONSORT 2010, we anticipate that BiFi REGs will expedite the peer review process for biofield therapy trials, facilitate attempts at trial replication and help to inform decision-making in the clinical practice of biofield therapies.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Biofield therapies: Guidelines for reporting clinical trials
    Hammerschlag, Richard
    Sprengel, Meredith L.
    Baldwin, Ann L.
    EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2024, 20 (02) : 196 - 205
  • [2] Biofield therapies: Guidelines for reporting clinical trials
    Hammerschlag, Richard
    Sprengel, Meredith L.
    Baldwin, Ann L.
    COMPLEMENTARY THERAPIES IN MEDICINE, 2024, 82
  • [3] Biofield Therapies: Guidelines for Reporting Clinical Trials
    Hammerschlag, Richard
    Sprengel, Meredith
    Baldwin, Ann L.
    JOURNAL OF INTEGRATIVE AND COMPLEMENTARY MEDICINE, 2024, 30 (02): : 133 - 145
  • [4] GUIDELINES FOR REPORTING CLINICAL TRIALS
    不详
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1973, 87 (03): : 557 - &
  • [5] GUIDELINES FOR REPORTING CLINICAL TRIALS
    CHILTON, NW
    BARBANO, JP
    JOURNAL OF PERIODONTAL RESEARCH, 1974, : 207 - 208
  • [6] GUIDELINES FOR THE REPORTING OF CLINICAL-TRIALS
    GREEN, SJ
    FLEMING, TR
    SEMINARS IN ONCOLOGY, 1988, 15 (05) : 455 - 461
  • [7] GUIDELINES FOR REPORTING CLINICAL-TRIALS
    BERTINO, JR
    JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (01) : 1 - 1
  • [8] Guidelines for Designing and Reporting Clinical Trials in Vitiligo
    Gonzalez, Urba
    Whitton, Maxine
    Eleftheriadou, Viktoria
    Pinart, Mariona
    Batchelor, Jonathan
    Leonardi-Bee, Jo
    ARCHIVES OF DERMATOLOGY, 2011, 147 (12) : 1428 - 1436
  • [9] Biofield therapies and psychoneuroimmunology
    Mills, Paul J.
    Jain, Shamini
    BRAIN BEHAVIOR AND IMMUNITY, 2010, 24 (08) : 1229 - 1230
  • [10] Guidelines for the reporting of renal artery revascularization in clinical trials
    Rundback, JH
    Sacks, D
    Kent, KC
    Cooper, C
    Jones, D
    Murphy, T
    Rosenfield, K
    White, C
    Bettmann, M
    Cortell, S
    Puschett, J
    Clair, DG
    Cole, P
    JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2002, 13 (10) : 959 - 974